Display options
Cite
Calcagnì A, Kors L, Verschuren E, et al. Modelling TFE renal cell carcinoma in mice reveals a critical role of WNT signaling. Elife. 2016;5doi: 10.7554/eLife.17047.
Calcagnì, A., Kors, L., Verschuren, E., De Cegli, R., Zampelli, N., Nusco, E., Confalonieri, S., Bertalot, G., Pece, S., Settembre, C., Malouf, G. G., Leemans, J. C., de Heer, E., Salvatore, M., Peters, D. J., Di Fiore, P. P., & Ballabio, A. (2016). Modelling TFE renal cell carcinoma in mice reveals a critical role of WNT signaling. eLife, 5. https://doi.org/10.7554/eLife.17047
Calcagnì, Alessia, et al. "Modelling TFE renal cell carcinoma in mice reveals a critical role of WNT signaling." eLife vol. 5 (2016). doi: https://doi.org/10.7554/eLife.17047
Calcagnì A, Kors L, Verschuren E, De Cegli R, Zampelli N, Nusco E, Confalonieri S, Bertalot G, Pece S, Settembre C, Malouf GG, Leemans JC, de Heer E, Salvatore M, Peters DJ, Di Fiore PP, Ballabio A. Modelling TFE renal cell carcinoma in mice reveals a critical role of WNT signaling. Elife. 2016 Sep 26;5. doi: 10.7554/eLife.17047. PMID: 27668431; PMCID: PMC5036965.
Copy Download .nbib Format: NLM
Share it on

Elife. 2016 Sep 26;5. doi: 10.7554/eLife.17047.

Modelling TFE renal cell carcinoma in mice reveals a critical role of WNT signaling.

eLife

Alessia Calcagnì, Lotte Kors, Eric Verschuren, Rossella De Cegli, Nicolina Zampelli, Edoardo Nusco, Stefano Confalonieri, Giovanni Bertalot, Salvatore Pece, Carmine Settembre, Gabriel G Malouf, Jaklien C Leemans, Emile de Heer, Marco Salvatore, Dorien Jm Peters, Pier Paolo Di Fiore, Andrea Ballabio

Affiliations

  1. Telethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Naples, Italy.
  2. Department of Pathology, Academical Medical Center, Amsterdam, The Netherlands.
  3. Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  4. Department of Human Genetics, Leiden University Medical Center, Leiden, Netherlands.
  5. Molecular Medicine Program, European Institute of Oncology, Milan, Italy.
  6. IFOM, The FIRC Institute for Molecular Oncology Foundation, Milan, Italy.
  7. Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  8. Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States.
  9. Jan and Dan Duncan Neurological Research Institute, Texas Children Hospital, Houston, United States.
  10. Medical Genetics, Federico II University, Naples, Italy.
  11. Medical Genetics, Department of Medical and Translational Sciences, Federico II University, Naples, Italy.
  12. Department of Medical Oncology Groupe Hospitalier Pitie-Salpetriere, University Paris 6, Paris, France.
  13. Assistance Publique Hopitaux de Paris, University Paris 6, Paris, France.
  14. Faculty of Medicine Pierre et Marie Curie, University Paris 6, Paris, France.
  15. Institut Universitaire de Cancerologie GRC5, University Paris 6, Paris, France.
  16. IRCCS-SDN, Naples, Italy.

PMID: 27668431 PMCID: PMC5036965 DOI: 10.7554/eLife.17047

[No abstract available.]

Keywords: TFEB; WNT pathway; cancer biology; human biology; medicine; mouse; renal cell carcinoma

Conflict of interest statement

The authors declare that no competing interests exist.

References

  1. Arch Pathol Lab Med. 2012 Apr;136(4):410-7 - PubMed
  2. Methods Cell Biol. 2015;126:45-62 - PubMed
  3. Am J Surg Pathol. 2010 Sep;34(9):1295-303 - PubMed
  4. J Cell Biol. 2005 May 9;169(3):425-34 - PubMed
  5. Oncogene. 2000 Jan 6;19(1):69-74 - PubMed
  6. Curr Pharm Des. 2013;19(4):634-64 - PubMed
  7. Int J Cancer. 2010 May 15;126(10):2426-36 - PubMed
  8. EMBO Mol Med. 2016 Jan 19;8(2):73-6 - PubMed
  9. Genes Dev. 1994 Nov 15;8(22):2770-80 - PubMed
  10. Med Hypotheses. 1995 Nov;45(5):486-90 - PubMed
  11. Sci Signal. 2012 Jun 12;5(228):ra42 - PubMed
  12. Nat Med. 2007 Dec;13(12):1490-5 - PubMed
  13. Clin Lab Med. 2005 Jun;25(2):363-78 - PubMed
  14. Neoplasma. 2012;59(1):1-5 - PubMed
  15. Hum Pathol. 2002 Jan;33(1):68-79 - PubMed
  16. EMBO J. 2012 Mar 7;31(5):1095-108 - PubMed
  17. Am J Surg Pathol. 2005 Feb;29(2):230-40 - PubMed
  18. Clin Cancer Res. 2014 Aug 1;20(15):4129-40 - PubMed
  19. Semin Cancer Biol. 2013 Feb;23 (1):46-55 - PubMed
  20. Cancer Res. 2007 Feb 1;67(3):919-29 - PubMed
  21. Am J Pathol. 2001 Jul;159(1):179-92 - PubMed
  22. Oncogene. 2005 Dec 8;24(55):8205-10 - PubMed
  23. Mod Pathol. 2007 Dec;20(12):1217-29 - PubMed
  24. Sci Signal. 2014 Jan 21;7(309):ra9 - PubMed
  25. J Exp Med. 1996 Mar 1;183(3):1185-92 - PubMed
  26. Pathol Int. 2000 Sep;50(9):725-30 - PubMed
  27. Hum Mol Genet. 2011 Oct 1;20(19):3852-66 - PubMed
  28. Hum Pathol. 2014 Jan;45(1):59-64 - PubMed
  29. Ann Oncol. 2010 Sep;21(9):1834-8 - PubMed
  30. Genome Biol. 2004;5(10):R80 - PubMed
  31. Cancer Res. 1999 Aug 15;59(16):3880-2 - PubMed
  32. Proc Natl Acad Sci U S A. 2003 May 13;100(10):6051-6 - PubMed
  33. Cancer Cell. 2014 Mar 17;25(3):282-303 - PubMed
  34. Am J Surg Pathol. 2012 Jan;36(1):35-42 - PubMed
  35. Mol Cell Biol. 1998 Dec;18(12):6930-8 - PubMed
  36. Cancer Res. 1998 Jun 15;58(12):2520-3 - PubMed
  37. Hum Mol Genet. 2009 Jul 15;18(14):2532-42 - PubMed
  38. Autophagy. 2012 May 1;8(5):826-37 - PubMed
  39. Proc Natl Acad Sci U S A. 2015 Feb 3;112(5):E420-9 - PubMed
  40. Clin Cancer Res. 2009 Feb 15;15(4):1170-6 - PubMed
  41. J Am Soc Nephrol. 2002 Jul;13(7):1824-36 - PubMed
  42. J Immunol Methods. 1983 Dec 16;65(1-2):55-63 - PubMed
  43. Arch Pathol Lab Med. 2012 Dec;136(12 ):1541-51 - PubMed
  44. Cell Cycle. 2006 Dec;5(24):2839-41 - PubMed
  45. Pathol Int. 2000 Dec;50(12):945-52 - PubMed
  46. Nucleic Acids Res. 2002 Jan 1;30(1):207-10 - PubMed
  47. Am J Surg Pathol. 2008 May;32(5):656-70 - PubMed
  48. Oncogene. 1997 Oct;15(18):2233-9 - PubMed
  49. Am J Surg Pathol. 2002 Mar;26(3):281-91 - PubMed
  50. Bioinformatics. 2001 Jun;17(6):509-19 - PubMed
  51. N Engl J Med. 2016 Jan 14;374(2):135-45 - PubMed
  52. Int J Clin Exp Pathol. 2013 Jun 15;6(7):1452-7 - PubMed
  53. Nature. 2015 Aug 20;524(7565):361-5 - PubMed
  54. Cell Mol Life Sci. 2014 Jul;71(13):2483-97 - PubMed
  55. Hum Mol Genet. 2007 Dec 15;16(24):3188-96 - PubMed
  56. Science. 2011 Jun 17;332(6036):1429-33 - PubMed
  57. Nat Rev Urol. 2014 Aug;11(8):465-75 - PubMed
  58. Genesis. 2006 May;44(5):225-32 - PubMed
  59. Rare Tumors. 2009 Dec 28;1(2):e53 - PubMed
  60. Trends Mol Med. 2006 Sep;12(9):406-14 - PubMed
  61. J Clin Invest. 2005 Oct;115(10):2894-903 - PubMed
  62. Oncogene. 2006 Jun 26;25(27):3866-84 - PubMed
  63. Cell. 2006 Nov 3;127(3):469-80 - PubMed
  64. Science. 2009 Jul 24;325(5939):473-7 - PubMed
  65. Histopathology. 2008 Nov;53(5):533-44 - PubMed
  66. J Biol Chem. 2002 Aug 16;277(33):29577-83 - PubMed
  67. Cancer Res. 1998 Mar 1;58(5):896-9 - PubMed
  68. Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8847-51 - PubMed
  69. Hum Mol Genet. 2003 Jul 15;12(14):1661-9 - PubMed
  70. J Am Soc Nephrol. 2016 Dec;27(12 ):3589-3599 - PubMed
  71. Am J Surg Pathol. 2012 Sep;36(9):1327-38 - PubMed
  72. Pediatr Nephrol. 2000 Nov;15(1-2):151-6 - PubMed
  73. Nat Genet. 2015 Jan;47(1):13-21 - PubMed
  74. Cancer Res. 2001 Feb 1;61(3):854-8 - PubMed

Publication Types

Grant support